{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:03:42Z","timestamp":1789491822763,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.103883","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:44:52Z","timestamp":1787388292000},"page":"103883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["FOXA1 transcriptionally upregulates LMAN2 to promote breast cancer progression"],"prefix":"10.1016","volume":"104","author":[{"given":"Zhitao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103883_bib1","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.tice.2026.103883_bib2","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1038\/s41598-025-93883-9","article-title":"The global burden of breast cancer among women of reproductive age: a comprehensive analysis","volume":"15","author":"Cai","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103883_bib3","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.tice.2026.103883_bib4","article-title":"Metabolic reprogramming in breast cancer: pathways driving progression, drug resistance, and emerging therapeutics","volume":"1880","author":"Garg","year":"2025","journal-title":"BBA-Rev. Cancer"},{"key":"10.1016\/j.tice.2026.103883_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.tice.2026.103883_bib6","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.tice.2026.103883_bib7","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2174\/1570180820666230607102138","article-title":"Gardenin B, A Natural Inhibitor for USP7: in vitro evaluation and in silico identification","volume":"21","author":"Siyu","year":"2024","journal-title":"Lett. Drug. Des. Discov."},{"key":"10.1016\/j.tice.2026.103883_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/0118744710254730231114181358","article-title":"Impact of Radiation Therapy on Serum Humanin and MOTS-c levels in patients with lung or breast cancer","volume":"17","author":"Ayse G\u00fclbin","year":"2024","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.tice.2026.103883_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.tice.2026.103883_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.tice.2026.103883_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2025.100013","article-title":"Thymoquinone suppresses cell growth and induces ferroptosis in renal cell carcinoma by reducing SERPINH1 expression","volume":"22","author":"Luo","year":"2025","journal-title":"Lett. Drug. Des. Discov."},{"key":"10.1016\/j.tice.2026.103883_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.curpro.2025.100061","article-title":"Resveratrol regulates ferroptosis and endometrial cancer progression by inhibiting CEBPA-mediated FAM83B expression","volume":"22","author":"Ma","year":"2025","journal-title":"Curr. Proteom."},{"key":"10.1016\/j.tice.2026.103883_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-020-00230-3","article-title":"Targeting ferroptosis in breast cancer","volume":"8","author":"Li","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.tice.2026.103883_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41420-021-00473-5","article-title":"The role of ferroptosis in breast cancer patients: a comprehensive analysis","volume":"7","author":"Wu","year":"2021","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.tice.2026.103883_bib15","doi-asserted-by":"crossref","first-page":"25462","DOI":"10.1074\/jbc.M116.729202","article-title":"Adaptor Protein CD2AP and L-type Lectin LMAN2 regulate exosome cargo protein trafficking through the golgi complex *","volume":"291","author":"Kwon","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tice.2026.103883_bib16","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1074\/jbc.M112188200","article-title":"Involvement of VIP36 in intracellular transport and secretion of glycoproteins in polarized Madin-Darby Canine Kidney (MDCK) Cells","volume":"277","author":"Hara-Kuge","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tice.2026.103883_bib17","article-title":"Comprehensive analysis of the expression and prognostic value of LMAN2 in HER2+ Breast Cancer","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.tice.2026.103883_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70448","article-title":"LMAN2 promotes breast cancer tumorigenesis and drug resistance by interacting with MAPK9 via Activation of the MAPK Pathway","volume":"13","author":"Feng","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.tice.2026.103883_bib19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ejca.2008.04.020","article-title":"Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance","volume":"44","author":"Habashy","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tice.2026.103883_bib20","article-title":"The role of transcription factor FOXA1\/C2\/M1\/O3\/P1\/Q1 in breast cancer","volume":"103","author":"Yuan","year":"2024","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.tice.2026.103883_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41420-024-01936-1","article-title":"FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer","volume":"10","author":"Liu","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.tice.2026.103883_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10549-020-06068-5","article-title":"FOXA1 is a determinant of drug resistance in breast cancer cells","volume":"186","author":"Kumar","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"issue":"19","key":"10.1016\/j.tice.2026.103883_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194699","article-title":"FOXA1 in breast cancer: a luminal marker with promising prognostic and predictive impact","volume":"14","author":"Metovic","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2026.103883_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/onc.2012.62","article-title":"FOXA1 represses the molecular phenotype of basal breast cancer cells","volume":"32","author":"Bernardo","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.tice.2026.103883_bib25","first-page":"47","article-title":"Relationship between LMAN2 expression in HR-positive breast cancer tissues and patient prognosis and its effect on proliferation and migration of MCF-7 cells","volume":"31","author":"ChangJiao","year":"2024","journal-title":"Chin. J. Cancer Biother"},{"key":"10.1016\/j.tice.2026.103883_bib26","first-page":"145","article-title":"L-type lectins in ER-golgi intermediate compartment","volume":"20","author":"Gupta","year":"2012","journal-title":"Funct. Clin. Appl."},{"key":"10.1016\/j.tice.2026.103883_bib27","doi-asserted-by":"crossref","first-page":"37178","DOI":"10.1074\/jbc.M505757200","article-title":"Sugar-binding Properties of VIP36, an intracellular animal lectin operating as a cargo receptor*","volume":"280","author":"Kamiya","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tice.2026.103883_bib28","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1074\/jbc.M709384200","article-title":"Molecular basis of sugar recognition by the human L-type Lectins ERGIC-53, VIPL, and VIP36*","volume":"283","author":"Kamiya","year":"2008","journal-title":"J. Biol. Chemi"},{"key":"10.1016\/j.tice.2026.103883_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/bcb-2024-0166","article-title":"LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt\/ERK\/NF-\u03baB signaling","volume":"103","author":"Xiao","year":"2025","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.tice.2026.103883_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116029","article-title":"Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro","volume":"303","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tice.2026.103883_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12915-025-02240-9","article-title":"p53-mediated suppression of the SLC7 A11\/GPX4 signaling pathway promotes trophoblast ferroptosis in preeclampsia","volume":"23","author":"Liao","year":"2025","journal-title":"BMC Biol."},{"key":"10.1016\/j.tice.2026.103883_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10565-025-10010-0","article-title":"Insights into emerging mechanisms of ferroptosis: new regulators for cancer therapeutics","volume":"41","author":"Xu","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.tice.2026.103883_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s13008-026-00182-4","article-title":"Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression","author":"Gao","year":"2026","journal-title":"Cell. Div."},{"key":"10.1016\/j.tice.2026.103883_bib34","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1007\/s12013-025-01801-7","article-title":"DCTPP1 is transcriptionally activated by FOXA1 to affect cisplatin sensitivity in triple-negative breast cancer via suppression of ferroptosis","volume":"83","author":"He","year":"2025","journal-title":"Cell. Biochem. Biophys."},{"key":"10.1016\/j.tice.2026.103883_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","article-title":"Ferroptosis inducers as promising radiosensitizer agents in cancer radiotherapy","volume":"17","author":"Fatemeh-Jalali","year":"2024","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.tice.2026.103883_bib36","article-title":"SLC7A11: the Achilles heel of tumor?","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103883_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.tice.2026.103883_bib38","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s12672-025-03510-2","article-title":"Research of SLC7A11 to estimate the prognosis and immune infiltration landscape for breast cancer","volume":"16","author":"Xue","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.tice.2026.103883_bib39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41417-025-00927-3","article-title":"The dual role of GPX4 in breast cancer: mechanisms of therapeutic resistance and potential for novel targeted therapies","volume":"32","author":"Gu","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tice.2026.103883_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2015.03.008","article-title":"FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer","volume":"361","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2026.103883_bib41","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1248\/bpb.b17-00307","article-title":"FOXA1 Induces E-cadherin expression at the protein level via suppression of slug in epithelial breast cancer cells","volume":"40","author":"Anzai","year":"2017","journal-title":"Biol. Pharma Bull."},{"key":"10.1016\/j.tice.2026.103883_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3892\/ol.2023.13720","article-title":"LPCAT1 is transcriptionally regulated by FOXA1 to promote breast cancer progression and paclitaxel resistance","volume":"25","author":"Zhang","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tice.2026.103883_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626005781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626005781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:20:48Z","timestamp":1789489248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626005781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":43,"alternative-id":["S0040816626005781"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103883","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXA1 transcriptionally upregulates LMAN2 to promote breast cancer progression","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103883"}}